AC Immune (ACIU) Free Cash Flow Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -402.45% |
| Sep 30, 2025 | -44.33% |
| Jun 30, 2025 | -123.65% |
| Mar 31, 2025 | -1,548.68% |
| Dec 31, 2024 | 137.64% |
| Sep 30, 2024 | -8.02% |
| Jun 30, 2024 | 617.89% |
| Mar 31, 2024 | 108.13% |
| Dec 31, 2023 | 9.45% |
| Sep 30, 2023 | -7.48% |
| Jun 30, 2023 | 20.65% |
| Mar 31, 2023 | 26.67% |
| Dec 31, 2022 | 15.07% |
| Sep 30, 2022 | 8.92% |
| Jun 30, 2022 | -16.51% |
| Mar 31, 2022 | -33.71% |
| Dec 31, 2021 | 0.75% |
| Sep 30, 2021 | 8.52% |
| Jun 30, 2021 | -12.23% |
| Mar 31, 2021 | -86.86% |
| Dec 31, 2020 | -148.16% |
| Sep 30, 2020 | -199.21% |
| Jun 30, 2020 | 8.00% |
| Mar 31, 2020 | -114.67% |
| Dec 31, 2019 | 35.73% |
| Sep 30, 2019 | 241.30% |
| Jun 30, 2019 | -139.37% |
| Mar 31, 2019 | 616.01% |
| Dec 31, 2018 | -100.06% |
| Sep 30, 2018 | 99.96% |
| Jun 30, 2018 | 16.87% |
| Mar 31, 2018 | -15.05% |
| Dec 31, 2017 | 317,053.58% |
| Sep 30, 2017 | -304,679.89% |
| Jun 30, 2017 | -1,474.68% |
| Mar 31, 2017 | -49.42% |
| Dec 31, 2016 | -39.13% |